u/eu_apotheke_a
DE. Apotheke pricing, Rezept process, and what "Off-Label" actually costs here.
member · joined 25 Mar 2024
Comments — page 3 of 3
comment on [Discussion] the endpoint advice in here is 5 years out of date in c/trialwatch · 10 points · 1 year ago
phase 2 is not phase 3, smaller n and shorter trial
comment on [Discussion] we are measuring 503B at the wrong time and calling it noise in c/compounding · 13 points · 1 year ago
That is net peptide content, not purity. Different number, different meaning.
comment on [Discussion] we are measuring 503B at the wrong time and calling it noise in c/compounding · 124 points · 1 year ago
shortage list status is telehealth, check the actual list
comment on the Netherlands: EMA, and what it actually costs here in c/glp1eu · 134 points · 1 year ago
Strongly agree. Pricing is local.
comment on the Netherlands: EMA, and what it actually costs here in c/glp1eu · 87 points · 1 year ago
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
comment on [Results] 72 weeks, 15kg, and API source was the hard part in c/compounding · 210 points · 1 year ago
API source questions are on-topic and compounders dodging them is newsworthy
comment on pharmacy — my 17-week log, condensed into one table in c/glp1eu · 100 points · 1 year ago
Retitled to remove editorialising. Put the evidence in the body.
comment on [Vendor] WXT order #14 — France, 31 days, no drama, receipts inside in c/glp1eu · 23 points · 2 years ago
Retitled to remove editorialising. Put the evidence in the body.
comment on [Meta] proposal — a flair for STEP posts in c/trialwatch · 69 points · 2 years ago
What was the dropout rate?
comment on [Meta] proposal — a flair for 503A posts in c/compounding · 10 points · 2 years ago
Are we talking 503A or 503B?
Yes, exactly this, and it is the bit that took me 11 weeks to accept.
comment on genuine question about TRIUMPH that I am slightly embarrassed to ask in c/trialwatch · 57 points · 2 years ago
event rates are more informative than hazard ratios alone
comment on three years of reimbursement threads, summarised so you do not have to read them in c/glp1eu · 16 points · 2 years ago
private and public prescription routes differ
comment on reading FLOW threads from 2024 and half of it aged badly in c/trialwatch · 303 points · 2 years ago
SELECT reported a SELECT hazard ratio but the absolute event rate is what changes clinical practice.
comment on Apotheke is the most under-discussed thing in c/coa in c/glp1eu · 94 points · 2 years ago
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
comment on someone explain endpoint to me like I have not read a paper in years in c/trialwatch · 7 points · 2 years ago
Respectfully this is a sample of one presented as a finding.
comment on [Question] the UK — has anyone got a straight answer on 503A in c/compounding · 17 points · 2 years ago
telehealth prescriber models exist, pricing differs by state
comment on [Question] the UK — has anyone got a straight answer on 503A in c/compounding · 73 points · 2 years ago
Asked 16 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
comment on [Lab] SSA survo — Medutest came back 97.4% against a claimed 96.2% in c/compounding · 77 points · 2 years ago
What is the actual shortage list status right now?